Toni K. Choueiri
0000-0002-9201-3217
Publication & Citation Trends
Publications
0 total
Abstract PR002: Design of dual-targeted fine-tuned immune restoring (DFIR) CAR-T cell therapy to treat advanced renal cell carcinoma (RCC)
Cited by 0
Semantic Scholar
Abstract B024: A mitochondrial plasma proteomic signature identifies metastatic chromophobe RCC
Cited by 0
Semantic Scholar
Abstract A003: Hsp70 gene expression is enriched in lymphocytes in renal cell carcinoma patients that respond to immune checkpoint inhibitors
Cited by 0
Semantic Scholar
Abstract PR005: KRAS amplification as de novo oncogenic alteration and therapeutic target in human cancers
Cited by 0
Semantic Scholar
Single-cell transcriptomic investigation of the cell-of-origin and oncogenic pathways across variant histologies of renal cell carcinoma.
Cited by 0
Semantic Scholar
Cell-free DNA epigenomic profiling enables noninvasive detection and monitoring of translocation renal cell carcinoma
Cited by 1
Semantic Scholar
Integrative Clinical and Molecular Evaluation of Renal Cell Carcinoma with Merlin Protein Deficiency and Biallelic Loss of NF2.
Cited by 0
Semantic Scholar
Abstract PR014: Shared germline architecture across renal cell carcinoma, coronary artery disease, and clonal hematopoiesis implicates a regulatory haplotype at the TERT promoter
Cited by 0
Semantic Scholar
Research Topics
Renal cell carcinoma treatment
(1332)
Cancer Immunotherapy and Biomarkers
(677)
Cancer Genomics and Diagnostics
(557)
Renal and related cancers
(492)
Bladder and Urothelial Cancer Treatments
(425)
Affiliations
Université Claude Bernard Lyon 1
AstraZeneca (United Kingdom)
Broad Institute
University of Essex
Boston University